These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27900667)

  • 21. Human Milk Expression After Domperidone Treatment in Postpartum Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Taylor A; Logan G; Twells L; Newhook LA
    J Hum Lact; 2019 Aug; 35(3):501-509. PubMed ID: 30481478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production.
    Zuppa AA; Sindico P; Orchi C; Carducci C; Cardiello V; Romagnoli C
    J Pharm Pharm Sci; 2010; 13(2):162-74. PubMed ID: 20816003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing breast milk production with Domperidone in mothers of preterm neonates (EMPOWER trial).
    Asztalos EV; Campbell-Yeo M; daSilva OP; Kiss A; Knoppert DC; Ito S
    BMC Pregnancy Childbirth; 2012 Aug; 12():87. PubMed ID: 22935052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the Effect of a 14-Day Course of Domperidone on Breast Milk Production: A Per-Protocol Analysis from the EMPOWER Trial.
    Asztalos EV; Kiss A; daSilva OP; Campbell-Yeo M; Ito S; Knoppert D;
    Breastfeed Med; 2019 Mar; 14(2):102-107. PubMed ID: 30543461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Domperidone. Discovering new choices for lactating mothers.
    Henderson A
    AWHONN Lifelines; 2003; 7(1):54-60. PubMed ID: 12674062
    [No Abstract]   [Full Text] [Related]  

  • 26. Barley malt-based composition as a galactagogue - a randomized, controlled trial in preterm mothers.
    Wesolowska A; Pietrzak B; Kociszewska-Najman B; Wielgos M; Czajkowski K; Wietrak E; Karzel K; Borszewska-Kornacka MK
    Ginekol Pol; 2021; 92(2):118-125. PubMed ID: 33751522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domperidone for Treatment of Low Milk Supply in Breast Pump-Dependent Mothers of Hospitalized Premature Infants: A Clinical Protocol.
    Haase B; Taylor SN; Mauldin J; Johnson TS; Wagner CL
    J Hum Lact; 2016 May; 32(2):373-81. PubMed ID: 26905341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Wang Nam Yen herbal tea on human milk production: A randomized controlled trial.
    Saejueng K; Nopsopon T; Wuttikonsammakit P; Khumbun W; Pongpirul K
    PLoS One; 2022; 17(1):e0247637. PubMed ID: 35100251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of galactogogues in the breastfeeding mother.
    Forinash AB; Yancey AM; Barnes KN; Myles TD
    Ann Pharmacother; 2012 Oct; 46(10):1392-404. PubMed ID: 23012383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced lactation and exclusive breast milk feeding of adopted premature twins.
    Szucs KA; Axline SE; Rosenman MB
    J Hum Lact; 2010 Aug; 26(3):309-13. PubMed ID: 20571140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Domperidone on Breast Milk Production in Mothers of Sick Neonates: A Randomized, Double-Blinded, Placebo-Controlled Trial.
    Khorana M; Wongsin P; Torbunsupachai R; Kanjanapattanakul W
    Breastfeed Med; 2021 Mar; 16(3):245-250. PubMed ID: 33202169
    [No Abstract]   [Full Text] [Related]  

  • 32. Psychiatric Manifestations of Withdrawal Following Domperidone Used as a Galactagogue.
    Majdinasab E; Haque S; Stark A; Krutsch K; Hale TW
    Breastfeed Med; 2022 Dec; 17(12):1018-1024. PubMed ID: 36367713
    [No Abstract]   [Full Text] [Related]  

  • 33. "Fear of stopping" vs "wanting to get off the medication": exploring women's experiences of using domperidone as a galactagogue - a qualitative study.
    Zizzo G; Rumbold AR; Grzeskowiak LE
    Int Breastfeed J; 2021 Dec; 16(1):92. PubMed ID: 34886887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the Prescribing Process of Domperidone for Low Milk Supply: A Qualitative Study Among Mothers, IBCLCs, and Family Doctors.
    Tauritz Bakker LA; van Dijk L; van den Bemt PMLA
    J Hum Lact; 2021 Nov; 37(4):748-760. PubMed ID: 33180685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.
    Renoux C; Dell'Aniello S; Khairy P; Marras C; Bugden S; Turin TC; Blais L; Tamim H; Evans C; Steele R; Dormuth C; Ernst P;
    Br J Clin Pharmacol; 2016 Aug; 82(2):461-72. PubMed ID: 27062307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis.
    Leelakanok N; Holcombe A; Schweizer ML
    Clin Drug Investig; 2016 Feb; 36(2):97-107. PubMed ID: 26649742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation.
    Prescrire Int; 2008 Apr; 17(94):67. PubMed ID: 18540123
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine.
    Doggrell SA; Hancox JC
    Expert Opin Drug Saf; 2014 Jan; 13(1):131-8. PubMed ID: 24147629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Author response to dr newman.
    Anderson PO
    J Hum Lact; 2013 May; 29(2):263-4. PubMed ID: 23592425
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to commentary: the galactogogue bandwagon.
    Newman J
    J Hum Lact; 2013 May; 29(2):263. PubMed ID: 23592424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.